Literature DB >> 2880946

Subjective reports of the effects of MDMA in a clinical setting.

G Greer, R Tolbert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2880946     DOI: 10.1080/02791072.1986.10472364

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


× No keyword cloud information.
  73 in total

1.  Ecstasy and the dance of death.

Authors:  J A Henry
Journal:  BMJ       Date:  1992-07-04

2.  Ecstasy and the dance of death.

Authors:  G Greer
Journal:  BMJ       Date:  1992-09-26

Review 3.  Hallucinogens: an update.

Authors:  John H Halpern
Journal:  Curr Psychiatry Rep       Date:  2003-10       Impact factor: 5.285

4.  5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats.

Authors:  J H Kehne; R A Padich; T C McCloskey; V L Taylor; C J Schmidt
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

5.  Fatal poisoning by MDMA (ecstasy) and MDEA: a case report.

Authors:  V Fineschi; A Masti
Journal:  Int J Legal Med       Date:  1996       Impact factor: 2.686

6.  Ecstasy and neurodegeneration. Advice is that "less is more".

Authors:  J Merrill
Journal:  BMJ       Date:  1996-08-17

Review 7.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 8.  Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

Authors:  Lee E Dunlap; Anne M Andrews; David E Olson
Journal:  ACS Chem Neurosci       Date:  2018-07-12       Impact factor: 4.418

9.  Effects of repeated 3,4-methylenedioxymethamphetamine administration on neurotransmitter efflux and sensory-evoked discharge in the ventral posterior medial thalamus.

Authors:  M A Starr; M E Page; B D Waterhouse
Journal:  J Pharmacol Exp Ther       Date:  2011-10-07       Impact factor: 4.030

10.  Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy.

Authors:  John J D Turner; Andrew C Parrott; Julia Goodwin; Derek G Moore; Sarah Fulton; Meeyoung O Min; Lynn T Singer
Journal:  J Psychopharmacol       Date:  2013-12-10       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.